BIO-key Q3 revenue falls 28% to $1.55M; net loss widens; raises $3.1M via warrant exercise

BIO KEY INTERNATIONAL INC

Q3 2025 revenue $1.55M (down 28% YoY); net loss ($964,849) or ($0.15) per share vs ($738,959) ($0.39) in Q3'24.
Full year 2025 revenue guidance $6.5-$7M.
On Oct 27, raised $3.1M gross via warrant exercise at $1.02/share (3.09M shares); used proceeds to prepay notes.
Launched EcoID III scanner; secured Middle East defense biometric deployment.
Balance sheet: $2.0M cash at Sep 30 vs $0.4M at Dec 31; total notes outstanding $675k.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.